Related references
Note: Only part of the references are listed.Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
COVID-19 and the cardiovascular system
Ying-Ying Zheng et al.
NATURE REVIEWS CARDIOLOGY (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hematological findings and complications of COVID-19
Evangelos Terpos et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Tomasz J. Guzik et al.
CARDIOVASCULAR RESEARCH (2020)
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
Liang Chen et al.
CARDIOVASCULAR RESEARCH (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
COVID-19: towards understanding of pathogenesis
Wei Cao et al.
CELL RESEARCH (2020)
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Brandon Michael Henry et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019
Shaobo Shi et al.
EUROPEAN HEART JOURNAL (2020)
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors
Iziah E. Sama et al.
EUROPEAN HEART JOURNAL (2020)
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
Luka Nicin et al.
EUROPEAN HEART JOURNAL (2020)
Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection
Simone Sala et al.
EUROPEAN HEART JOURNAL (2020)
Myocardial localization of coronavirus in COVID-19 cardiogenic shock
Guido Tavazzi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
First case of COVID-19 complicated with fulminant myocarditis: a case report and insights
Jia-Hui Zeng et al.
INFECTION (2020)
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
Ishan Paranjpe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
Behnood Bikdeli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Tao Chen et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
The association between treatment with heparin and survival in patients with Covid-19
Luis Ayerbe et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes
Denis Doyen et al.
LANCET (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
Riccardo M. Inciardi et al.
JAMA CARDIOLOGY (2020)
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Tao Guo et al.
JAMA CARDIOLOGY (2020)
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
Shaobo Shi et al.
JAMA CARDIOLOGY (2020)
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Waradon Sungnak et al.
NATURE MEDICINE (2020)
High Inflammatory Burden: A Potential Cause of Myocardial Injury in Critically Ill Patients With COVID-19
Yanjun Song et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
Brett L. Houston et al.
CLINICAL TRIALS (2020)
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
Girish N. Nadkarni et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Anticoagulation in critically ill patients on mechanical ventilation suffering from COVID-19 disease, The ANTI-CO trial: A structured summary of a study protocol for a randomised controlled trial
Nadir Kharma et al.
TRIALS (2020)
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial
Stefano Busani et al.
TRIALS (2020)
Surface electrocardiographic characteristics in coronavirus disease 2019: repolarization abnormalities associated with cardiac involvement
Liang Chen et al.
ESC HEART FAILURE (2020)
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
Anna Cristina Bertoldi Lemos et al.
THROMBOSIS RESEARCH (2020)
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
Behnood Bikdeli et al.
THROMBOSIS RESEARCH (2020)
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality
Henny H. Billett et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Myocardial injury and COVID-19: Serum hs-cTnl level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease
Jiatian Cao et al.
THERANOSTICS (2020)
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
Luka Nicin et al.
EUROPEAN HEART JOURNAL (2020)
Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection
Simone Sala et al.
EUROPEAN HEART JOURNAL (2020)
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors
Iziah E. Sama et al.
EUROPEAN HEART JOURNAL (2020)
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019
Shaobo Shi et al.
EUROPEAN HEART JOURNAL (2020)
Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
Joshua P. Metlay et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
John A. Kellum et al.
CRITICAL CARE (2013)
Share Paper
